CRISPR Therapeutics AG (CRSP)

Finanzdaten der CRISPR Therapeutics AG-Aktie (CRSP)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	201.21	-	70.00	100.00	0.006
Operating Expenses	0.60% 131.62	132.41	165.22	164.49	131.55
Benefits Costs and Expenses	0.10% 111.63	111.74	146.82	151.75	120.06
Costs And Expenses	0.10% 111.63	111.74	146.82	151.75	120.06
Operating Income/Loss	152.55% 69.58	-132.41	-95.22	-64.49	-131.54
Nonoperating Income/Loss	3.26% 20.00	20.67	18.41	12.74	11.49
Income/Loss From Continuing Operations Before Tax	180.17% 89.58	-111.74	-76.82	-51.74	-120.05
Income Tax Expense/Benefit	43.45% 0.233	0.412	0.923	1.32	-9.476
Income/Loss From Continuing Operations After Tax	179.67% 89.35	-112.15	-77.74	-53.06	-110.58
Net Income/Loss	179.67% 89.35	-112.15	-77.74	-53.06	-110.58
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.80% 0.1575	79.41	79.09	78.68	0.1988
Diluted Average Shares	99.80% 0.1575	79.41	79.09	78.68	0.1988
Basic Earnings Per Share	180.14% 1.13	-1.41	-0.98	-0.67	-1.40
Diluted Earnings Per Share	180.14% 1.13	-1.41	-0.98	-0.67	-1.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-